AKT1 and ovarian carcinoma: A primary finding of this study is that CXCR2-driven cancer progression involves upregulation of its own ligands such as CXCL1 and CXCL2 by potentiating NF-κB activation via EGFR-transactivated Akt signaling followed by accelerated ovarian cancer cell proliferation, migration and invasion.